Our team is ready to answer your specific questions and concerns.
Fluid and electrolyte disturbances: Sodium retention Fluid retention Congestive heart failure in susceptible patients Potassium loss Hypokalemic alkalosis Hypertension Musculoskeletal: Muscle weakness Steroid myopathy Loss of muscle mass Osteoporosis Vertebral compression fractures Aseptic necrosis of femoral and humeral heads Pathologic fracture of long bones Gastrointestinal: Peptic ulcer with possible subsequent perforation and hemorrhage Pancreatitis Abdominal distention Ulcerative esophagitis Dermatological: Impaired wound healing Thin fragile skin Facial erythema Increased sweating May suppress reactions to skin tests Petechiae and ecchymoses Neurological: Convulsions Increased intracranial pressure with papilledema (pseudotumor cerebri) usually after treatment Vertigo Headache Ophthalmic: Posterior subcapsular cataracts Increased intraocular pressure Glaucoma Endocrine: Menstrual irregularities Development of cushingoid state Suppression of growth in children Secondary adrenocortical and pituitary unresponsiveness, particularly in times of stress, as in trauma, surgery, or illness Decreased carbohydrate tolerance Manifestations of latent diabetes mellitus Increased requirements for insulin or oral hypoglycemic agents in diabetics Metabolic: Negative nitrogen balance due to protein catabolism Miscellaneous: Hyperpigmentation or hypopigmentation Subcutaneous and cutaneous atrophy Sterile abscess Postinjection flare, following intra-articular use Charcot-like arthropathy Itching, burning, tingling in the ano-genital region A
A 10 mg vial targeting 10 mg/mL concentration requires 1.0 mL of water
I understand that I may have to take the medication for the rest of my life, and the risks associated with stopping medication
Pulmonary sarcomatoid carcinomas commonly harbor either potentially targetable genomic alterations or high tumor mutational burden as observed by comprehensive genomic profiling
General Subcutaneous Injection Process Clean the injection area with an alcohol swab and allow to dry completely Draw the appropriate dose into an insulin syringe (29-31 gauge, 0.5 inch needle) Pinch a fold of skin and subcutaneous tissue between thumb and forefinger Insert the needle at a 45-degree angle into the pinched skin fold Release the skin fold and inject slowly over 5-10 seconds Withdraw needle and apply gentle pressure with a cotton ball if needed Do not rub or massage the injection site Wrist-Specific Injection Sites Local injection near the injury delivers higher peptide concentrations to target tissue compared to distant systemic injection
